Acupuncture and moxibustion significantly improved the efficacy rate for treating heart failure compared to traditional treatment alone (OR 2.61; 95% CI 1.84-3.72; p<0.0001).
Systematic Review (n=2,499)
Does acupuncture and moxibustion added to medication improve heart function in patients with heart failure?
Acupuncture and moxibustion as an adjunct to standard medication may improve surrogate markers of heart function and exercise capacity in heart failure patients, though the quality of evidence is limited by methodological flaws in the included trials.
Effect estimate: OR 2.61 (95% CI 1.84-3.72)
p-value: p=<0.0001
Background . Acupuncture and moxibustion (A 3.72], I 2 = 0%, p0.0001) and a significantly improved left ventricular ejection fraction (LVEF) (mean difference (MD) = 6.34, 95%CI = 4.11, 8.57, I 2 = 93%, p0.0001), cardiac output (CO) (MD = 1.02, 95%CI = 0.65, 1.39, I 2 = 94%, p0.0001), 6-minute walk test (6MWT) (MD = 43.6, 95%CI = 37.43, 49.77, I 2 = 0%, p0.0001), and reduced brain-type natriuretic peptide (BNP) (MD = −227.99, 95%CI = −337.30, −118.68, I 2 = 96%, p0.0001). Adverse events were inadequately reported in most studies. Conclusions . A&M may be a promising intervention as an adjunctive therapy to medication for treating heart failure. However, the evidence was inconclusive. Further large and rigorously designed RCTs are needed for verification.
Liang et al. (2019) conducted a systematic review in Heart failure (n=2,499). Acupuncture and moxibustion vs. Traditional treatment was evaluated on Efficacy rate (OR 2.61, 95% CI 1.84-3.72, p=<0.0001). Acupuncture and moxibustion significantly improved the efficacy rate for treating heart failure compared to traditional treatment alone (OR 2.61; 95% CI 1.84-3.72; p<0.0001).